Seqens Personal Care Article
To produce high purity polymers for biomedical use, a purification step is usually required. After the synthesis step(s) of polymers, heterogeneous polymeric populations in terms of size and/or chemical properties could be obtained as well as the generation of by-product(s)
We sat down with Eric Busseron, R&D manager for Pharma Polymers in Aramon and Rajesh Shukla, R&D Director at our Boston'Lab to discuss polymers in healthcare and the main challenges when developing polymers.
We asked 6 questions to our Fine Chemicals R&D manager, Pierre-Antoine Bonnardel. Pierre manages a chemical development team in the Seqens’Lab, and he explains how his team works on custom projects and shares insights on two major customized solutions
Tissue engineering and overall regenerative medicine, involve complex processes that often require combining multiple strategies. Materials used in these approaches, range from metals and ceramics to natural and synthetic polymers as well as their microcomposites and nanocomposites.
